Abstract
Background:Thalidomide has been successful use in patients with refractory Crohn disease (CD) in recent years.Methods:We collected the data of a postoperative CD patient who was prescribed thalidomide to induce remission and reviewed the relevant literatures.Results:A 51-year-old female was diagnosed as CD after an urgent terminal intestinal resection and presented endoscopic recurrence despite the prophylactic treatment with azathioprine (AZA). Fortunately, she achieved mucosal healing (MH) at a low dose of thalidomide for 15 months.Conclusion:Thalidomide is effective to induce MH in the postoperative CD endoscopic recurrence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
